Banque Cantonale Vaudoise’s InMed Pharmaceuticals INM Stock Holding History

Banque Cantonale Vaudoise’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	6	–	–	﹤0.01%	440
2026 Q1	$0	Hold	6	–	–	﹤0.01%	905
2025 Q4	$0	Hold	6	–	–	﹤0.01%	846
2025 Q3	$0	Hold	6	–	–	﹤0.01%	837
2025 Q2	$1K	Hold	6	–	–	﹤0.01%	784
2025 Q1	$0	Buy	+6	New	+$20	﹤0.01%	831
2024 Q3	$0	Buy	+6	New	+$31	﹤0.01%	880
2022 Q3	–	Hold	0	–	–	–	1256
2022 Q2	–	Hold	0	–	–	–	1313
2022 Q1	–	Hold	0	–	–	–	1349
2021 Q4	–	Hold	0	–	–	–	1361
2021 Q3	–	Hold	0	–	–	–	1326
2021 Q2	–	Hold	0	–	–	–	1254
2021 Q1	–	Hold	0	–	–	–	1165
2020 Q4	–	Hold	0	–	–	–	1091

Other funds holding INM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

UFM

Ursa Fund Management Danville, California $1.28B AUM 89.08% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Banque Cantonale Vaudoise's INM Position: Q2 2026 in Review

Banque Cantonale Vaudoise held its InMed Pharmaceuticals (INM) position steady in Q2 2026 at 6 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

Banque Cantonale Vaudoise first reported a position in INM in Q3 2024 and has held it in 7 quarters since. 20 funds tracked by Wall St. Rank hold INM as of Q2 2026.

Banque Cantonale Vaudoise held 6 shares of InMed Pharmaceuticals worth $1K as of Q2 2026.
Banque Cantonale Vaudoise left its InMed Pharmaceuticals share count unchanged in Q2 2026.
InMed Pharmaceuticals made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #440 holding.
Banque Cantonale Vaudoise first reported a position in InMed Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
20 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.